Aspirin may interfere with ADT treatment Prostate Cancer

Recent studies have raised a red flag of caution; it may not be wise also to be taking aspirin while on a hormone blockade (ADT). Recent findings show that for some men taking aspirin, which is commonly used in low daily doses for prevention of heart attack and stroke, may result in liver toxicity. Liver [...]

Bone Turnover Marker Data And Additional PSA Progression Safety Analysis For Toremifene 80 Mg Phase III ADT Clinical Trial

GTx, Inc. (Nasdaq: GTXI) has conducted a number of clinical trials using toremifene citrate in both the treatment of breast and prostate cancer. Older women and men as well as women and men being treated for both breast and prostate cancers are subject to bone loss leading to an increased risk of falls and fractures. [...]

ADT and Hot Flashes

Did you have androgen deprivation therapy (ADT)? If you have you probably experienced hot flashes. Up to 80% of men treated with ADT for prostate cancer will experience hot flashes, ranging from very mild to very severe. Along with hot flashes many of us will also have insomnia, fatigue, irritability and a host of other [...]

Exisulind On The Horizon

A study which was funded by Cell Pathways Inc., developer of the drug Exisulind, suggest that Exisulind may delay disease progression in men with recurrent prostate cancer according to Dr. Erik Goluboff, Assistant Professor of Urology at Columbia University College of Physicians & Surgeons, Director of Urology at The Allen Pavilion of New York-Presbyterian Hospital, [...]

HIFU For Recurrent Prostate Cancer

High Intensity Focused Ultrasound (HIFU) is a minimally invasive procedure that uses ultrasound energy to destroy cancerous tissue with focused sound waves. It has been used for a period of time in both Europe and Mexico as a primary prostate cancer treatment. Currently, in the United States there is a phase III trial being conducted [...]

By |2017-10-19T10:57:01-04:00September 26th, 2008|Advanced Prostate Cancer, Clinical Trials, HIFU, Uncategorized|0 Comments
Go to Top